Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families

Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families

Bibliographic Details
Main Authors:	Oros, Kathleen K, Leblanc, Guy, Arcand, Suzanna L, Shen, Zhen, Perret, Chantal, Mes-Masson, Anne-Marie, Foulkes, William D, Ghadirian, Parviz, Provencher, Diane, Tonin, Patricia N
Format:	Online
Language:	English
Published:	BioMed Central 2006
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464093/

Similar Items

A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
by: Belanger, Moria H, et al.
Published: (2015)

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome
by: Wojnarowicz, Paulina M., et al.
Published: (2012)

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
by: Birch, Ashley H., et al.
Published: (2011)

Germline TP53 mutational spectrum in French Canadians with breast cancer
by: Arcand, Suzanna L, et al.
Published: (2015)

Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
by: Fleury, Hubert, et al.
Published: (2015)

Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
by: Tischkowitz, Marc, et al.
Published: (2013)

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
by: Hamel, Nancy, et al.
Published: (2003)

BRCA1 founder mutations and ovarian cancer in Belarus
by: Savanevich, A, et al.
Published: (2015)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
by: Metcalfe, Kelly, et al.
Published: (2014)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
by: J. Maksimenko, et al.
Published: (2018-06-01)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
by: Wappenschmidt, B, et al.
Published: (2001)

The Icelandic founder mutation BRCA2 999del5: analysis of expression
by: Mikaelsdottir, Evgenia K, et al.
Published: (2004)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
by: Caleca, Laura, et al.
Published: (2014)

A Founder Mutation of the BRCA1-Gene in Western Sweden
by: Einbeigi, Zakaria, et al.
Published: (1999)

BRCA1 founder mutations compared to ovarian cancer in Belarus
by: Savanevich, Alena, et al.
Published: (2014)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
by: Angela R. Solano, et al.
Published: (2018-08-01)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
by: Ewald, Ingrid P, et al.
Published: (2011)

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
by: Janavičius, Ramūnas
Published: (2010)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
by: Kotsopoulos, Joanne, et al.
Published: (2005)

The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations
by: Rudkin, Teresa M, et al.
Published: (2006)

The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles
by: Quinn, Michael CJ, et al.
Published: (2009)

Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
by: Létourneau, Isabelle J, et al.
Published: (2012)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
by: Metcalfe, K, et al.
Published: (2011)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
by: Iqbal, J, et al.
Published: (2012)

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity
by: Wojnarowicz, P, et al.
Published: (2012)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
by: Kotsopoulos, Joanne, et al.
Published: (2012)

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
by: Laroche-Clary, A, et al.
Published: (2015)

BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
by: Artur Kowalik, et al.

BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African
by: Laraqui, Abdelilah, et al.
Published: (2015)

The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies
by: Pereira, Lutécia H Mateus, et al.
Published: (2007)

Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population
by: Mahfoudh, Wijden, et al.
Published: (2011)

Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas
by: Pinto, Pedro, et al.
Published: (2016)

Haplotype variation in founders of the <em>Mauremys annamensis</em> population kept in European Zoos
by: Barbora Somerova, et al.
Published: (2015-06-01)

The Founders of Neurology
by: Lewis, P. D.
Published: (1972)

Reminiscences of the founder
by: PSM
Published: (2008)

Founders of Cybernetics
by: B.H., Rudall
Published: (2000)

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G
by: Claes, Kathleen, et al.
Published: (1999)

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis
by: Bu, Rong, et al.
Published: (2016)

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
by: Ławniczak, Małgorzata, et al.
Published: (2016)

Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro
by: Dery, Marie-Claude, et al.
Published: (2007)